Immix Biopharma Inc.

2.02
-0.04 (-1.94%)
At close: Jan 17, 2025, 3:59 PM
2.08
2.97%
After-hours Jan 17, 2025, 04:48 PM EST

Immix Biopharma Statistics

Share Statistics

Immix Biopharma has 27.51M shares outstanding. The number of shares has increased by 7.73% in one year.

Shares Outstanding 27.51M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.21%
Owned by Institutions (%) n/a
Shares Floating 16.38M
Failed to Deliver (FTD) Shares 93
FTD / Avg. Volume 0.06%

Short Selling Information

The latest short interest is 434.94K, so 1.58% of the outstanding shares have been sold short.

Short Interest 434.94K
Short % of Shares Out 1.58%
Short % of Float 2.65%
Short Ratio (days to cover) 2.94

Valuation Ratios

The PE ratio is -7.78 and the forward PE ratio is -3.13.

PE Ratio -7.78
Forward PE -3.13
PS Ratio 0
Forward PS 4.6
PB Ratio 7.31
P/FCF Ratio -10.5
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Immix Biopharma Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.

Current Ratio 5.32
Quick Ratio 5.32
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.94% and return on capital (ROIC) is -99.78%.

Return on Equity (ROE) -0.94%
Return on Assets (ROA) -0.77%
Return on Capital (ROIC) -99.78%
Revenue Per Employee 0
Profits Per Employee -1.10M
Employee Count 14
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 26.41K
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -63.6% in the last 52 weeks. The beta is 0.1, so Immix Biopharma 's price volatility has been higher than the market average.

Beta 0.1
52-Week Price Change -63.6%
50-Day Moving Average 2.04
200-Day Moving Average 2.04
Relative Strength Index (RSI) 45.63
Average Volume (20 Days) 159.74K

Income Statement

Revenue n/a
Gross Profit -5.47K
Operating Income -16.14M
Net Income -15.43M
EBITDA -16.14M
EBIT n/a
Earnings Per Share (EPS) -0.89
Full Income Statement

Balance Sheet

The company has 17.51M in cash and 0 in debt, giving a net cash position of 17.51M.

Cash & Cash Equivalents 17.51M
Total Debt 0
Net Cash 17.51M
Retained Earnings -53.41M
Total Assets 25.14M
Working Capital 16.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.37M and capital expenditures -52.09K, giving a free cash flow of -11.42M.

Operating Cash Flow -11.37M
Capital Expenditures -52.09K
Free Cash Flow -11.42M
FCF Per Share -0.66
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IMMX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -44.06%
FCF Yield -20.56%
Dividend Details

Analyst Forecast

The average price target for IMMX is $7, which is 246.5% higher than the current price. The consensus rating is "Buy".

Price Target $7
Price Target Difference 246.5%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score -1.54
Piotroski F-Score 2